Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Solid Tumors × relatlimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 3 Neoplasms 2 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Neoplasm Metastasis 1 Liver Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Solid Tumors 1

Interventions

Injections 15 Carboplatin 14 Docetaxel 10 pembrolizumab 7 durvalumab 6 Cisplatin 6 linifanib 5 Paclitaxel 5 talazoparib 4 olaparib 4 Panobinostat 4 Nivolumab 4 Itraconazole 4 Bevacizumab 4 zimberelimab 3 sintilimab 3 depatuxizumab 3 atezolizumab 3 ST 1481 3 S 1 (combination) 3 Rifampin 3 Pemetrexed 3 Fluorouracil 3 trifluridine tipiracil drug combination 2 tremelimumab 2 tislelizumab 2 tesetaxel 2 spartalizumab 2 motesanib diphosphate 2 ixabepilone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05498480 2024-02-20

RELATIVITY-111

Bristol-Myers Squibb

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡